Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.

Inclusion Criteria:

• Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.

Exclusion Criteria:

• Patients diagnosed with cancer or with a history of cancer treatment.
• Participation may be restricted at the discretion of the medical team.
• Infants and young children under the age of 10.